GENPACT Pharmalink
The Healthcare Industry’s No. 1 choice for Regulatory Affairs Solutions
Genpact Pharmalink works with leading life sciences organizations including 9 of the top 10, helping their regulatory affairs functions cut time-to-market, boost efficiency and ensure compliance, ultimately delivering superior patient and business value.
Life sciences companies are facing stringent regulatory requirements in developed markets and the challenge of satisfying dramatically variable requirements in emerging markets, resulting in penalties for non-compliance and costly delays. Genpact Pharmalink works with leading life sciences organizations including 9 of the top 10, helping their regulatory affairs affairs functions cut time-to-market, boost efficiency and ensure compliance to deliver superior patient and business value.
Genpact (NYSE: G) is a global professional services firm that makes business transformation real. We drive digital-led innovation and digitally-enabled intelligent operations for our clients, guided by our experience running thousands of processes for hundreds of Global Fortune 500 companies. We think with design, dream in digital, and solve problems with data and analytics. We obsess over operations and focus on the details – all 80,000+ of us. From New York to New Delhi and more than 20 countries in between, Genpact has the end-to-end expertise to connect every dot, reimagine every process, and reinvent companies’ ways of working. We know that rethinking each step from start to finish will create better business outcomes. Whatever it is, we’ll be there with you – putting data and digital to work to create bold, lasting results – because transformation happens here.
Genpact began in 1997 as a business unit within General Electric. In January 2005, Genpact became an independent company to bring our process expertise and unique DNA in Lean management to clients beyond GE, and then in August 2007, we became a publicly-traded company. Bain Capital became Genpact’s largest shareholder in November 2012, with the strategic objective to grow the company further. Since December 31, 2005, we have expanded from 19,000+ employees and annual revenues of US$491.90 million to 80,000+ employees and annual revenues of US$2.74 billion as of December 31, 2017.
 | |
| | |
| GENPACT Pharmalink | |
|---|---|
| Type | Public |
| Industry | Pharmaceuticals |
| Founded | 1998 |
| Headquarters | Vandervell House Vanwall Business Park Maidenhead, Berkshire SL6 4UB United Kingdom |
| Number of employees | 201-500 employees |
A History of Regulatory Affairs Expertise
People are the heart of what Genpact Pharmalink does. We only work with the very best in the industry, and invest heavily in their training, development and professional happiness. We know that having the right people consistently managing our client’s business is the key to our continued success. Whether our clients need simple market intelligence or assistance filing submissions, or require more complex expertise such as compliance services or management of post-licensing activities, we have established a history of success in guiding clients through their regulatory affairs challenges. Learn more about our expertise and our global network of world class consultants, and think about the difference it can make for your organization.
In 2013 Pharmalink Consulting Limited was acquired by Genpact Inc, who had identified our potential as the leading provider of regulatory services for nearly all of the 20 largest global life sciences companies for over 15 years. Pharmalink adds significant depth and specialist expertise to Genpact's Life Sciences vertical, which includes regulatory consulting, outsourcing, and technology capabilities.
Verification history
1,977 days ago
2,508 days ago- View all verifications
